Learn more about the results of a large study that has identified two factors that may help predict the chance that breast cancer will come back in the breast or nearby areas better than the cancer’s stage.

Get highlights of two studies that provide insight into why some women with early-stage breast cancer choose to have a double mastectomy and the risk of complications they may experience after this surgery.

What would it be like to meet the inventor of the investigational drug that is keeping you alive? Janet Freeman-Daily found out firsthand at the 2014 ASCO Annual Meeting.

Prostate cancer patient advocate Alvin Chin describes how his experiences in Chicago satisfied his “sweet tooth” for relevant and important cancer information.

Activating and amplifying the body’s immune response to cancer is an exciting area of research. See how it is being used to better treat advanced or high-risk melanoma and cervical cancer in these four studies presented in Chicago today.

Get highlights of four pivotal studies that reveal new ways to optimize commonly used chemotherapy, hormone therapy, and newer targeted drugs, and answer critical questions about the effectiveness of two common treatment regimens for advanced colorectal cancer.

Learn more about four studies that show the potential of new targeted therapies for advanced ovarian, lung, and thyroid cancers and chronic lymphocytic leukemia.

Researchers are continuing to find new ways to reduce the side effects of treatment and improve quality of life. Get highlights of five studies presented today at the ASCO Annual Meeting.

Find out why more than 25,000 oncology professionals are gathering in Chicago May 30-June 3, 2014.

Get highlights of five studies showing promise in novel targeted therapies, cancer prevention, and patient care that will be presented at ASCO’s 50th Annual Meeting.